244 related articles for article (PubMed ID: 8556099)
21. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
Khouri C; Planès S; Logerot S; Villier C; Mallaret M
Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
[TBL] [Abstract][Full Text] [Related]
22. Fever development in neuroleptic malignant syndrome during treatment with olanzapine and clozapine.
Szota A; Ogłodek E; Araszkiewicz A
Pharmacol Rep; 2013; 65(2):279-87. PubMed ID: 23744413
[TBL] [Abstract][Full Text] [Related]
23. Clozapine withdrawal catatonia and neuroleptic malignant syndrome: a case report.
Lee JW; Robertson S
Ann Clin Psychiatry; 1997 Sep; 9(3):165-9. PubMed ID: 9339882
[TBL] [Abstract][Full Text] [Related]
24. Olanzapine induced neuroleptic malignant syndrome--a case review.
Kogoj A; Velikonja I
Hum Psychopharmacol; 2003 Jun; 18(4):301-9. PubMed ID: 12766935
[TBL] [Abstract][Full Text] [Related]
25. Neuroleptic malignant syndrome associated with long-term clozapine treatment: report of a case and results of a clozapine rechallenge.
Huang TL
Chang Gung Med J; 2001 Aug; 24(8):522-5. PubMed ID: 11601195
[TBL] [Abstract][Full Text] [Related]
26. NMS after clozapine initiation.
Skarpathiotakis M; Westreich N
J Am Acad Child Adolesc Psychiatry; 2005 Nov; 44(11):1101-2. PubMed ID: 16239854
[No Abstract] [Full Text] [Related]
27. Fever, confusion, acute kidney injury: is this atypical neuroleptic malignant syndrome following polypharmacy with clozapine and risperidone?
Cherry S; Siskind D; Spivak V; Wysoczanski D; Halangoda P
Australas Psychiatry; 2016 Dec; 24(6):602-603. PubMed ID: 27194777
[TBL] [Abstract][Full Text] [Related]
28. [Neuroleptic malignant syndrome after 30 years treatment with clozapine: a rarely seen differential diagnosis on intensive care units].
Franzen D; Burkhard J; Corti N; Schüpbach D; Fontanel D; Stäubli M
Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Feb; 41(2):125-7. PubMed ID: 16493563
[TBL] [Abstract][Full Text] [Related]
29. Neuroleptic malignant syndrome associated with clozapine use.
Anderson ES; Powers PS
J Clin Psychiatry; 1991 Mar; 52(3):102-4. PubMed ID: 2005071
[TBL] [Abstract][Full Text] [Related]
30. Clozapine-induced neuroleptic malignant syndrome in an adolescent.
Matheson KM; Gray G
J Child Adolesc Psychopharmacol; 2012 Aug; 22(4):322-4. PubMed ID: 22897669
[No Abstract] [Full Text] [Related]
31. A Case Report: Atypical Neuroleptic Malignant Syndrome on Clozapine and Mood Stabilizers.
Amador EC; Kassam A; Hopp C; Cunningham EA
J Clin Psychopharmacol; 2019; 39(5):518-519. PubMed ID: 31425460
[No Abstract] [Full Text] [Related]
32. Risperidone-induced neuroleptic malignant syndrome: a case report and review.
Meterissian GB
Can J Psychiatry; 1996 Feb; 41(1):52-4. PubMed ID: 8919425
[TBL] [Abstract][Full Text] [Related]
33. [Neuroleptic malignant syndrome after treatment with olanzapine].
Emborg C
Ugeskr Laeger; 1999 Mar; 161(10):1424-5. PubMed ID: 10085753
[TBL] [Abstract][Full Text] [Related]
34. Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique.
Hasan S; Buckley P
Am J Psychiatry; 1998 Aug; 155(8):1113-6. PubMed ID: 9699705
[TBL] [Abstract][Full Text] [Related]
35. Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome.
Musselman ME; Browning LA; Parker D; Saely S
Ann Pharmacother; 2011 Nov; 45(11):e61. PubMed ID: 21972252
[TBL] [Abstract][Full Text] [Related]
36. Neuroleptic malignant syndrome secondary to aripiprazole initiation in a clozapine-intolerant patient.
Patel MK; Brunetti L
Am J Health Syst Pharm; 2010 Aug; 67(15):1254-9. PubMed ID: 20651315
[TBL] [Abstract][Full Text] [Related]
37. Neuroleptic Malignant Syndrome.
Pileggi DJ; Cook AM
Ann Pharmacother; 2016 Nov; 50(11):973-981. PubMed ID: 27423483
[TBL] [Abstract][Full Text] [Related]
38. Neuroleptic malignant syndrome related to use of clozapine.
Trayer JS; Fidler DC
J Am Osteopath Assoc; 1998 Mar; 98(3):168-9. PubMed ID: 9558834
[TBL] [Abstract][Full Text] [Related]
39. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
Ozen ME; Yumru M; Savas HA; Cansel N; Herken H
World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349
[TBL] [Abstract][Full Text] [Related]
40. Atypical neuroleptic malignant syndrome associated with clozapine treatment.
Amore M; Zazzeri N; Berardi D
Neuropsychobiology; 1997; 35(4):197-9. PubMed ID: 9246221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
